Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Geron (GERN) Other Accumulated Expenses (2016 - 2024)

Historic Other Accumulated Expenses for Geron (GERN) over the last 14 years, with Q4 2024 value amounting to $2.1 million.

  • Geron's Other Accumulated Expenses rose 15565.11% to $2.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.1 million, marking a year-over-year increase of 15565.11%. This contributed to the annual value of $2.1 million for FY2024, which is 15565.11% up from last year.
  • Geron's Other Accumulated Expenses amounted to $2.1 million in Q4 2024, which was up 15565.11% from $3.2 million recorded in Q3 2024.
  • In the past 5 years, Geron's Other Accumulated Expenses ranged from a high of $3.2 million in Q3 2024 and a low of $366000.0 during Q2 2022
  • Over the past 5 years, Geron's median Other Accumulated Expenses value was $1.2 million (recorded in 2023), while the average stood at $1.3 million.
  • In the last 5 years, Geron's Other Accumulated Expenses surged by 45218.58% in 2023 and then plummeted by 1672.44% in 2024.
  • Geron's Other Accumulated Expenses (Quarter) stood at $388000.0 in 2020, then skyrocketed by 39.43% to $541000.0 in 2021, then dropped by 5.73% to $510000.0 in 2022, then surged by 59.61% to $814000.0 in 2023, then skyrocketed by 155.65% to $2.1 million in 2024.
  • Its Other Accumulated Expenses stands at $2.1 million for Q4 2024, versus $3.2 million for Q3 2024 and $1.7 million for Q2 2024.